Cargando…
CAFs/tumor cells co-targeting DNA vaccine in combination with low-dose gemcitabine for the treatment of Panc02 murine pancreatic cancer
In this study, we investigate the synergistic effect of gemcitabine (Gem) and a novel DNA vaccine in the treatment of pancreatic cancer in mice and explore the anti-tumor mechanism of this combination therapy. Fibroblast activation protein α-expressing cancer-associated fibroblasts (FAPα(+) CAFs), a...
Autores principales: | Geng, Fei, Dong, Ling, Bao, Xin, Guo, Qianqian, Guo, Jie, Zhou, Yi, Yu, Bin, Wu, Hui, Wu, Jiaxin, Zhang, Haihong, Yu, Xianghui, Kong, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420428/ https://www.ncbi.nlm.nih.gov/pubmed/36090474 http://dx.doi.org/10.1016/j.omto.2022.07.008 |
Ejemplares similares
-
ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma
por: Takhsha, Farnaz Sedigheh, et al.
Publicado: (2021) -
A novel in vitro model of metastasis supporting passive shedding hypothesis from murine pancreatic cancer Panc-02
por: Krzykawski, M. P., et al.
Publicado: (2019) -
Biodegradable Polymersomes for the Delivery of Gemcitabine to Panc-1 Cells
por: Sood, Nimil, et al.
Publicado: (2013) -
Pancreatic ductal adenocarcinoma cells regulated the gemcitabine‐resistance function of CAFs by LINC00460
por: Zhu, Xiao‐Xu, et al.
Publicado: (2022) -
Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases chemosensitivity to 5-fluorouracil and gemcitabine
por: Yang, Xiaoping, et al.
Publicado: (2019)